← Open Payments lookup

LYNN WOJTYSIAK: Open Payments

NPI 1992775670 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,204 in 70 payments from 15 companies in 2025. Trend: 2023 $1,551 · 2024 $1,823 · 2025 $1,204

Food & beverage: $1,204
CompanyPaymentsAmount
Kestra Medical Technology Services, Inc.6$337
E.R. Squibb & Sons, L.L.C.27$228
PFIZER INC.15$161
AstraZeneca Pharmaceuticals LP6$123
Boston Scientific Corporation2$73
Boehringer Ingelheim Pharmaceuticals, Inc.2$62
Novartis Pharmaceuticals Corporation3$57
Bayer Healthcare Pharmaceuticals Inc.2$32
Actelion Pharmaceuticals US, Inc.1$26
Esperion Therapeutics, Inc.1$25

Products named: Assure WCD, ELIQUIS, CAMZYOS, FARXIGA, VYNDAQEL, WATCHMAN FLX, JARDIANCE, LEQVIO.

Industry payments across MD — which companies pay providers there.